Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 28.06.16 in Vol 5, No 2 (2016): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5791):

(note that this is only a small subset of citations)

  1. Flamant M, Paul S, Roblin X. Golimumab for the treatment of ulcerative colitis. Expert Opinion on Biological Therapy 2017;17(7):879
    CrossRef
  2. Lopetuso L, Gerardi V, Papa V, Scaldaferri F, Rapaccini G, Gasbarrini A, Papa A. Can We Predict the Efficacy of Anti-TNF-α Agents?. International Journal of Molecular Sciences 2017;18(9):1973
    CrossRef